Stock 4005 NATIONAL MEDICAL CARE COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Financials National Medical Care Company

Equities

4005

SA139051UIH0

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E.
Other stock markets
 08:20:05 2024-06-03 am EDT 		5-day change 1st Jan Change
197.4 SAR +1.86% Intraday chart for National Medical Care Company +12.80% +13.19%
May. 23 National Medical Care Company Approves Cash Dividend for the Financial Period December 31, 2023, Payable on 12 June 2024 CI
May. 15 National Medical Care Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,180 2,395 2,808 3,314 7,822 8,853 - -
Enterprise Value (EV) 1 1,901 2,117 2,522 3,068 7,783 8,511 8,117 8,144
P/E ratio 27.2 x 24.6 x 20.6 x 19.5 x 32.5 x 30.7 x 25.9 x 25.4 x
Yield 4.12% 3.75% 1.6% 1.35% - 0.88% 0.96% 1.14%
Capitalization / Revenue 3.08 x 2.96 x 3.32 x 3.61 x 7.23 x 6.84 x 6.01 x 5.51 x
EV / Revenue 2.68 x 2.62 x 2.98 x 3.34 x 7.19 x 6.58 x 5.51 x 5.07 x
EV / EBITDA 11 x 12.4 x 12.3 x 12.5 x 26.8 x 23.2 x 18.9 x 17.5 x
EV / FCF 12.5 x 22.7 x 43.4 x 538 x 18.9 x 104 x 38.8 x 29.7 x
FCF Yield 8% 4.4% 2.3% 0.19% 5.3% 0.96% 2.58% 3.36%
Price to Book 2.11 x 2.31 x 2.5 x 2.62 x 5.38 x 5.33 x 4.65 x 4.14 x
Nbr of stocks (in thousands) 44,850 44,850 44,850 44,850 44,850 44,850 - -
Reference price 2 48.60 53.40 62.60 73.90 174.4 197.4 197.4 197.4
Announcement Date 2/23/20 3/29/21 3/1/22 3/5/23 2/27/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 708.4 809 845.4 917.9 1,082 1,294 1,473 1,607
EBITDA 1 172.9 170.3 205.4 244.5 290.3 366.3 430.1 466.2
EBIT 1 104.8 114.1 155.3 198.8 246.7 305.1 354.6 380.6
Operating Margin 14.8% 14.11% 18.37% 21.66% 22.81% 23.58% 24.08% 23.68%
Earnings before Tax (EBT) 1 102.7 123.3 164.4 198.5 264.6 310.9 390.9 371.9
Net income 1 80.09 97.27 136.4 170.1 240.9 290 351.9 378
Net margin 11.31% 12.02% 16.13% 18.53% 22.27% 22.41% 23.9% 23.52%
EPS 2 1.790 2.170 3.040 3.790 5.370 6.426 7.633 7.782
Free Cash Flow 1 152 93.18 58.11 5.703 412.7 81.9 209 273.8
FCF margin 21.46% 11.52% 6.87% 0.62% 38.15% 6.33% 14.19% 17.04%
FCF Conversion (EBITDA) 87.93% 54.71% 28.29% 2.33% 142.17% 22.36% 48.6% 58.74%
FCF Conversion (Net income) 189.84% 95.8% 42.62% 3.35% 171.31% 28.24% 59.4% 72.45%
Dividend per Share 2 2.000 2.000 1.000 1.000 - 1.736 1.898 2.245
Announcement Date 2/23/20 3/29/21 3/1/22 3/5/23 2/27/24 - - -
1SAR in Million2SAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1
Net sales 1 215.6 211.5 216.5 238.3 251.7 261.4 245.2 275.4 299.8 298.6
EBITDA - 46.04 - 60.45 58.18 - - - - -
EBIT 1 35.71 37.01 45.95 49.06 46.95 63.43 - 74.89 - 72.34
Operating Margin 16.57% 17.5% 21.23% 20.59% 18.66% 24.27% - 27.2% - 24.23%
Earnings before Tax (EBT) - - - - - - - - - -
Net income 1 36.71 30 42.01 42.62 55.45 56.27 47.8 73.38 63.48 81.29
Net margin 17.03% 14.19% 19.4% 17.89% 22.03% 21.53% 19.49% 26.65% 21.17% 27.23%
EPS 2 - - - 0.9500 1.230 1.250 1.070 1.640 1.410 1.810
Dividend per Share - - - - - - - - - -
Announcement Date 3/1/22 5/16/22 8/11/22 11/2/22 3/5/23 5/14/23 8/7/23 11/5/23 2/27/24 5/12/24
1SAR in Million2SAR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 279 278 286 246 38.9 342 736 709
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 152 93.2 58.1 5.7 413 81.9 209 274
ROE (net income / shareholders' equity) 7.89% 9.4% 12.6% 14.2% 17.7% 18.5% 18.1% 18.2%
ROA (Net income/ Total Assets) 5.82% 6.98% 9.11% 10.4% 12.3% 12.5% 13.5% 12.4%
Assets 1 1,376 1,394 1,496 1,636 1,964 2,320 2,616 3,048
Book Value Per Share 2 23.00 23.10 25.10 28.20 32.40 37.10 42.50 47.70
Cash Flow per Share 2 3.600 2.380 2.090 4.840 10.40 5.680 7.650 8.350
Capex 1 9.79 13.5 35.7 211 54 202 156 121
Capex / Sales 1.38% 1.67% 4.22% 23.01% 4.99% 15.63% 10.6% 7.52%
Announcement Date 2/23/20 3/29/21 3/1/22 3/5/23 2/27/24 - - -
1SAR in Million2SAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for National Medical Care Company

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
197.4 SAR
Average target price
202.3 SAR
Spread / Average Target
+2.50%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
NATIONAL MEDICAL CARE COMPANY Stock National Medical Care Company
+13.19% 2.32B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-23.96% 15.56B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
-2.70% 11.65B
IHH HEALTHCARE Stock IHH Healthcare
+2.65% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+2.58% 10.06B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+25.28% 8.7B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-6.06% 7.16B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+6.74% 6.85B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+1.97% 6.2B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-3.14% 4.32B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. 4005 Stock
  4. Financials National Medical Care Company